Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
motolimod (VTX 2337)
i
Other names:
VTX 2337, VTX2337, VTX-2337
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
BMS, Pfizer
Drug class:
TLR8 agonist
Related drugs:
‹
imiquimod (4)
SBT6050 (4)
BDC-1001 (2)
BDC-2034 (1)
SBT6290 (1)
BDB018 (0)
CV8102 (0)
EIK1001 (0)
GQ1007 (0)
NKTR-262 (0)
imiquimod intravesical (0)
ZG0895 (0)
STM-416 (0)
TransCon TLR7/8 Agonist (0)
MEDI9197 (0)
imiquimod (4)
SBT6050 (4)
BDC-1001 (2)
BDC-2034 (1)
SBT6290 (1)
BDB018 (0)
CV8102 (0)
EIK1001 (0)
GQ1007 (0)
NKTR-262 (0)
imiquimod intravesical (0)
ZG0895 (0)
STM-416 (0)
TransCon TLR7/8 Agonist (0)
MEDI9197 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
TLR8 overexpression
Squamous Cell Carcinoma of Head and Neck
TLR8 overexpression
Squamous Cell Carcinoma of Head and Neck
cetuximab + VTX 2337
Sensitive: D – Preclinical
cetuximab + VTX 2337
Sensitive
:
D
cetuximab + VTX 2337
Sensitive: D – Preclinical
cetuximab + VTX 2337
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login